Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
5-{3-[3-(2,4-dichloro-benzoyl)-ureido]-2-methyl-phenoxy}-pentanoic acid
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is an experimental small molecule with the chemical formula C20H20Cl2N2O5 and a molecular weight of approximately 439.29 g/mol[1][2]. It has been studied as a potential inhibitor of glycogen phosphorylase (muscle form), an enzyme involved in glycogen catabolism and glucose homeostasis[4]. The drug is not approved for any indication and has not advanced beyond preclinical or early experimental stages. No clinical trials or marketed products are associated with this compound.
- Other names
- 5-{3-[3-(2,4-dichloro-benzoyl)-ureido]-2-methyl-phenoxy}-pentanoic acid5-(3-{[(2,4-dichlorobenzoyl)carbamoyl]amino}-2-methylphenoxy)pentanoic acidAcide 5-(3-{[(2,4-dichlorobenzoyl)carbamoyl]amino}-2-méthylphénoxy)pentanoïquePentanoic acid, 5-[3-[[[(2,4-dichlorobenzoyl)amino]carbonyl]amino]-2-methylphenoxy]-
02
Targets
PYGM (Glycogen phosphorylase, muscle form)
Beyond the preview
Go deeper on 5-{3-[3-(2,4-dichloro-benzoyl)-ureido]-2-methyl-phenoxy}-pentanoic acid.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 5-{3-[3-(2,4-dichloro-benzoyl)-ureido]-2-methyl-phenoxy}-pentanoic acid.